McKinsey advises government on making a COVID-19 vaccine locally
Apr 20, 2021 â 2.22pm
Save
Share
McKinsey has won a three-month contract to provide âadvice on a business case for an onshore COVID-19 vaccine manufacturing capability utilising an mRNA platformâ for the
Department Of Industry, Science, Energy and Resources. The contract is worth $2.2 million. Vaccine experts have previously said that mRNA vaccines, including the Pfizer vaccine, could be manufactured in Australia but warned it would take a long time and a significant investment for this to be possible.
McKinsey to help it plot its future strategy, known internally as T25, even as the telco giant completes its sweeping, four-year T22 restructure. The firm also provided advice on Telstraâs T22 plan. A Telstra spokesperson said: âThe strategy is being driven by [Telstra CEO] Andy Penn and the strategy team at Telstra led by CFO Vicki Bradyâ.
Date Time
Net zero by 2050 only possible if renewables ramp up: expert
Australia will not achieve net zero emissions until well after 2050 at the rate emissions are declining, experts from The Australian National University (ANU) warn.
However, they argue that by accelerating deployment of solar and wind, Australia can reach 80 per cent emissions reductions within 20 years at low or negative cost. This would place Australia within striking distance of net zero in 2050.
The latest official data from the Clean Energy Regulator shows Australia is continuing to install solar and wind power much faster per person than any other country.
Professor Andrew Blakers said Australia has declining electricity emissions and declining electricity prices, as more renewables feed into the network.